Abstract
Globally, there is a clinical problem caused by rising antibiotic resistance. The latest advances in biosynthesis have intrigued scientists and researchers as they investigate its potential against dangerous bacteria. The current emphasis is on myconanosynthesis, copper oxide nanoparticle (CuO NPs) characterization, and antibacterial efficacy. The extracellular biosynthetic approach we employed to create the CuO NPs was friendly to the environment. From agricultural soil samples, Talaromyces versatilis was isolated. They were comparing its 18s rDNA sequencing allowed for identification. Culture filtrate extracts of fungi were used as the reducing agents to synthesis the nanoparticles. XRD and DLS analysis were used to determine copper oxide nanoparticles (CuO NPs) size and material characteristics. When tested against Gram-positive and Gram-negative bacteria from that Salmonella paratyphi, Serratia sp., and Enterococcus fecalis myconanosynthesized copper oxide nanoparticles (CuO NPs) demonstrated a maximal zone of inhibition. Additionally, molecular in vivo research will aid in the creation of a novel wide-spectrum antibacterial drug.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
